Kiniksa Pharmaceuticals International, plc (KNSA)
NASDAQ: KNSA · Real-Time Price · USD
76.80
+0.74 (0.97%)
Aug 10, 2026, 11:31 AM EDT - Market open

KNSA Stock Forecast

Stock Price Forecast

According to 8 analysts polled by S&P Global, KNSA stock has a consensus rating of "Strong Buy" and an average price target of $98. The average 1-year stock price forecast is 27.60% higher than the current stock price, while the lowest is $87 (+13.28%) and the highest is $108 (+40.63%).

Price Target: $98 (+27.60%)
Analyst Consensus: Strong Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price$87$98$98.5$108
Change+13.28%+27.60%+28.26%+40.63%

Analyst Ratings

The average analyst rating for KNSA stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Chart
RatingFeb '26Mar '26Apr '26May '26Jun '26Jul '26
Strong Buy777777
Buy111111
Hold000000
Sell000000
Strong Sell000000
Total888888

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Goldman Sachs
Goldman Sachs
Buy
Maintains
$75$90
BuyMaintains$75$90+17.19%Jul 30, 2026
Wedbush
Wedbush
Buy
Reiterates
$72$99
BuyReiterates$72$99+28.91%Jul 29, 2026
J.P. Morgan
J.P. Morgan
Buy
Reiterates
$72$107
BuyReiterates$72$107+39.32%Jul 29, 2026
Wells Fargo
Wells Fargo
Buy
Reiterates
$74$87
BuyReiterates$74$87+13.28%Jul 29, 2026
Citi
Citi
Buy
Maintains
$60$100
BuyMaintains$60$100+30.21%Jul 29, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
993.71M
from 677.56M
Increased by 46.66%
Revenue Next Year
1.22B
from 993.71M
Increased by 22.90%
EPS This Year
1.16
from 0.75
Increased by 54.33%
EPS Next Year
1.62
from 1.16
Increased by 39.74%
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
38.54M220.18M270.26M423.24M677.56M993.71M
Revenue Growth
-471.24%22.75%56.61%60.09%46.66%
Operating Income
-156.64M9.77M-25.20M-45.62M77.22M133.32M
Net Income
-157.92M183.36M14.08M-43.19M59.01M102.80M
EPS
----0.751.16
EPS Growth
-----54.33%
Forward PE
-170.84170.8442.9327.3266.35
Free Cash Flow
-83.56M-2.36M13.79M22.57M97.89M111.67M
No. Analysts
-----8
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
High998.0M
Avg993.7M
Low989.7M

Revenue Growth

Revenue Growth202620272028
High
47.3%
Avg
46.7%
Low
46.1%

EPS Forecast

EPS202620272028
High1.23
Avg1.16
Low1.07

EPS Growth

EPS Growth202620272028
High
64.0%
Avg
54.3%
Low
42.7%